Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Confirmatory, Placebo-controlled, Randomised, Double-blind, Single-dummy, Parallel Group, Ratio-finding Study in Constipated Pain Patients to Establish an Optimal Hydromorphone - Naloxone Ratio With an Improved Bowel Function and a Comparable Analgesic Efficacy Compared to Hydromorphone Alone

NCT00992576 is registered in ClinicalTrials.gov with Mundipharma Research GmbH & Co KG as lead sponsor.

NCT NCT00992576
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00992576 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Confirmatory, Placebo-controlled, Randomised, Double-blind, Single-dummy, Parallel Group, Ratio-finding Study in Constipated Pain Patients to Establish an Optimal Hydromorphone - Naloxone Ratio With an Improved Bowel Function and a Comparable Analgesic Efficacy Compared to Hydromorphone Alone
Lead sponsor
Mundipharma Research GmbH & Co KG
Phase
Phase 2/3
Overall status
Completed
Start date
January 31, 2010
Completion date
January 31, 2012
Enrollment
600 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

constipation